CAS 57-91-0|17alpha-Estradiol
| Common Name | 17alpha-Estradiol | ||
|---|---|---|---|
| CAS Number | 57-91-0 | Molecular Weight | 272.382 |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 445.9±45.0 °C at 760 mmHg |
| Molecular Formula | C18H24O2 | Melting Point | 176-180ºC(lit.) |
| MSDS | ChineseUSA | Flash Point | 209.6±23.3 °C |
| Symbol | GHS08 | Signal Word | Warning |
Names
| Name | 17α-estradiol |
|---|---|
| Synonym | More Synonyms |
17alpha-Estradiol BiologicalActivity
| Description | Alpha-Estradiol is a weak estrogen and a 5α-reductase inhibitor which is used as a topical medication in the treatment of androgenic alopecia. |
|---|---|
| Related Catalog | Signaling Pathways >>Metabolic Enzyme/Protease >>5 alpha ReductaseNatural Products >>SteroidsResearch Areas >>Inflammation/Immunology |
| Target | Human Endogenous Metabolite |
| In Vitro | Alpha-Estradiol (17 alpha-Estradiol) is a 5α-reductase inhibitor, and inhibits testosterone metabolism catalyzed by 5 alpha-reductase[1]. Alpha-Estradiol (17 Alpha-estradiol, 10 μM) attenuates LPS-induced inflammatory markers in both C57BL/6J male and female mouse embryonic fibroblast (MEF) cells, primary pre-adipocytes and differentiated 3T3-L1 adipocytes in an ERα-dependent manner, and such effects are through decreased NFκB-p65 and increased ERα protein expression[2]. |
| In Vivo | Alpha-Estradiol (17-alpha-estradiol, 0.01, 0.1, 1 μg) significantly reduces the percentage of central avascular/total retina area of the mouse pups. Alpha-Estradiol (1 μg) markedly decreasesmalondialdehyde (MDA) levels on postnatal days (PND) 9, 13, and 17 in retinas of hyperoxia-exposed pups. Alpha-Estradiol (1 μg) also decreases the number of NADPH-oxidase-positive cells, NADPH oxidase concentration and activity in retinas of the pups. In the 1.0-μg Alpha-Estradiol-treated pups, VEGF retinal concentrations are high on PND 9 but lower on PND 14 and 17. The best effect in retinas of 1.0-μg Alpha-Estradiol-treated pups is partly reversed by ICI182780 on PND 14 and 17[3]. |
| Cell Assay | Mouse embryonic fibroblast (MEF) cells are treated for the indicated time with Alpha-Estradiol (17 α-E2) or 17 β-E2 at 10 μM concentration. Inflammation is induced by LPS at a concentration of 10 ng/mL either alone or in combination with the respective estrogen[2]. |
| Animal Admin | Newborn mice are randomLy assigned to six groups according to the kind of treatment: room air with vehicle injection (control, group 1), hyperoxia with vehicle injection (control, group 2), hyperoxia with 0.01 μg Alpha-Estradiol injection (group 3), hyperoxia with 0.1 μg Alpha-Estradiol injection (group 4), hyperoxia with 1.0 μg Alpha-Estradiol injection (group 5), and hyperoxia with 1.0 μg Alpha-Estradiol and 10.0 μg ICI182780 injection (antagonist of estrogen receptor α and β) (group 6). The pups receive daily subcutaneous injections of either Alpha-Estradiol in vehicle [dissolved in ethanol and diluted in 0.05 mL/mouse of phosphate-buffered saline (PBS)] or vehicle alone from postnatal days (PND) 7-16. On PND 7, the pups in the hyperoxia and Alpha-Estradiol-treatment groups are exposed to hyperoxia (75 ± 2 % O2) for 5 days (PND 7-12) and then returned to normoxia (room air) for 5 days, along with the nursing mothers, whereas pups in the normoxia group are kept in normoxia from PND 7-17. The pups are humanely euthanized on PND 9, 13 (14), and 17[3]. |
| References | [1]. Schriefers H, et al. Inhibition of testosterone metabolism by 17-alpha-estradiol in rat liver slices. Arzneimittelforschung. 1991 Nov;41(11):1186-9. [2]. Santos RS, et al. The effects of 17 alpha-estradiol to inhibit inflammation in vitro. Biol Sex Differ. 2017 Sep 6;8:30. [3]. Zhang HB, et al. 17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model. Jpn J Ophthalmol. 2012 Jul;56(4):407-15. |
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 445.9±45.0 °C at 760 mmHg |
| Melting Point | 176-180ºC(lit.) |
| Molecular Formula | C18H24O2 |
| Molecular Weight | 272.382 |
| Flash Point | 209.6±23.3 °C |
| Exact Mass | 272.177643 |
| PSA | 40.46000 |
| LogP | 4.13 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.599 |
| InChIKey | VOXZDWNPVJITMN-SFFUCWETSA-N |
| SMILES | CC12CCC3c4ccc(O)cc4CCC3C1CCC2O |
| Storage condition | 0-6°C |
| Water Solubility | ethanol: 50 mg/mL, clear, colorless |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intramuscular
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 3 mg/kg
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Reproductive - Tumorigenic effects - uterine tumors
MUTATION DATA - TYPE OF TEST :
- DNA inhibition
- TEST SYSTEM :
- Human Cells - not otherwise specified
- DOSE/DURATION :
- 100 mg/L
- REFERENCE :
- JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- Volume(issue)/page/year: 10,143,1982
- TYPE OF TEST :
- DNA inhibition
- TEST SYSTEM :
- Human Cells - not otherwise specified
- DOSE/DURATION :
- 100 mg/L
- REFERENCE :
- JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- Volume(issue)/page/year: 10,143,1982
Safety Information
| Symbol | GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H351 |
| Precautionary Statements | P281 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R40;R48 |
| Safety Phrases | 53-45-24/25-22 |
| RIDADR | UN 2811 |
| WGK Germany | 3 |
| RTECS | KG3750000 |
Articles4
More Articles| Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2 , 207-12, (2006) Estrogen is a hormone critical in the development, normal physiology and pathophysiology of numerous human tissues. The effects of estrogen have traditionally been solely ascribed to estrogen receptor... | |
| Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone. J. Med. Chem. 52 , 7488-502, (2009) 17beta-Hydroxysteroid dehydrogenase type 7 (17beta-HSD7) catalyzes the reduction of estrone (E(1)) into estradiol (E(2)) and of dihydrotestosterone (DHT) into 5alpha-androstane-3beta,17beta-diol (3bet... | |
| The effect of steroids on the in vitro migration of washed human spermatozoa in modified Tyrode's solution or in fasting human blood serum. Fertil. Steril. 32(5) , 566-70, (1979) In modified Tyrode's solution, 17 beta-estradiol at concentrations between 0.1 microgram/ml and 320 nmoles/ml was effective in increasing human spermatozoal forward migration. 17 alpha-Estradiol, alth... |
Synonyms
| α-Estradiol |
| a-Estradiol |
| Oestra-1,3,5(10)-triene-3,17α-diol |
| alfatradiol |
| MFCD00064144 |
| (17a)-Estra-1,3,5(10)-triene-3,17-diol |
| 3,17α-Dihydroxyestra-1,3,5(10)-triene |
| Estra-1,3,5(10)-triene-3,17-diol, (17α)- |
| trans-4-Hydroxycrotonic acid |
| Epiestradiol |
| Epiestrol |
| Estra-1,3,5(10)-triene-3,17a-diol |
| 3,17-α-Dihydroxyoestra-1,3,5(10)-triene |
| (17α)-Estra-1,3,5(10)-triene-3,17-diol |
| 3,17a-Dihydroxyestra-1,3,5(10)-triene |
| Oestradiol-17a |
| 3,17a-Dihydroxyoestra-1,3,5(10)-triene |
| Oestra-1,3,5(10)-triene-3,17a-diol |
| 17-Epiestradiol |
| 17α-Oestradiol |
| 3,17α-Dihydroxyoestra-1,3,5(10)-triene |
| 17a-Estradiol |
| 17α-Estradiol |
| 17α estradiol |
| Oestradiol-17α |
| (8R,9S,13S,14S,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol |
| Epiestradial |
| Estradiol, 17α- |
| EINECS 200-023-8 |
| 13b-Methyl-1,3,5(10)-gonatriene-3,17a-diol |
| 17a-Oestradiol |
| 17alpha-Estradiol |
| 3,17-Dihydroxyestratriene |
| Estradiol-17alpha |
